28BIO, INC.

Profile

Company Names

28BIO, INC.
AXOSIM, INC.

Addresses

4224 HOUMA BLVD., SUITE 224, METAIRIE, LA 70006

1441 CANAL STREET STE 205, NEW ORLEANS, LA 70112

1441 CANAL STREET, SUITE 206, NEW ORLEANS, LA 70112

1441 CANAL STREET, NEW ORLEANS, LA 70116

Phone Numbers

504-407-7419

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$17,399,233.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-05-21 
$6,525,000.00 
$7,000,000.00 
$475,000.00 
Equity 
3
2024-11-08 
$3,684,771.00 
$4,751,652.00 
$1,066,881.00 
Equity 
2
2020-06-02 
$6,056,462.00 
$6,056,462.00 
$0.00 
Equity 
1
2019-02-19 
$1,133,000.00 
$2,500,000.00 
$1,367,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BENJAMIN 
 
CAPPIELLO 
EXECUTIVE OFFICER
J. LOWRY 
 
CURLEY 
EXECUTIVE OFFICER, DIRECTOR
LOWRY 
 
CURLEY 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
HARTUNG 
EXECUTIVE OFFICER
MICHAEL 
 
KATZ 
DIRECTOR
NIPPON RENEWAL PARTNERS LP   |  GLENROCK GLOBAL PARTNERS QP LP   |  GLENROCK GLOBAL PARTNERS BVI INC   |  GLENROCK GLOBAL PARTNERS AI LP   |  NIPPON RENEWAL PARTNERS LTD   |  REYNARD AMERICAN PARTNERS LP   |  YES TO INC   |  NIPPON RENEWAL PARTNERS, LP   |  GLENROCK GLOBAL PARTNERS (QP), L.P.   |  GLENROCK GLOBAL PARTNERS (B.V.I.), INC.   |  GLENROCK GLOBAL PARTNERS (AI), L.P.   |  NIPPON RENEWAL PARTNERS, LTD.   |  REYNARD INTERNATIONAL PARTNERS, LTD.   |  REYNARD AMERICAN PARTNERS, L.P.   |  KEYME, INC.   |  GLENROCK GLOBAL PARTNERS, L.P.   |  MPARTICLE, INC.   |  GLENROCK GLOBAL PARTNERS (BVI), INC.   |  AQR DELTA OFFSHORE FUND, L.P.   |  AQR DELTA SAPPHIRE FUND, L.P.   |  AQR MULTI-STRATEGY FUND V, L.P.   |  AQR INTERNATIONAL EQUITY FUND II, L.P.   |  AQR GLOBAL DEFENSIVE EQUITY FUND, L.P.   |  AQR EQUITY PLUS FUND, L.P.   |  AQR GLOBAL RISK PREMIUM TACTICAL OFFSHORE FUND LTD   |  AQR GLOBAL STOCK SELECTION OFFSHORE FUND (USD) LTD.   |  AQR OFFSHORE MULTI-STRATEGY FUND V LTD.   |  AQR GLOBAL ASSET ALLOCATION OFFSHORE FUND (USD) IV LTD.   |  AK OVERLAY PORTFOLIO, L.P.   |  AQR GLOBAL RISK PREMIUM OFFSHORE FUND (GBP) LTD.   |  AQR DELTA OFFSHORE FUND IV, L.P.   |  AQR REAL RETURN OFFSHORE FUND, L.P.   |  AQR DELTA XN FUND, L.P.   |  AQR CHURCHILL MASTER ACCOUNT, L.P.   |  AQR GLOBAL RISK PREMIUM FUND L P   |  AQR GLOBAL RISK PREMIUM OFFSHORE FUND III LTD.   |  AQR INTERNATIONAL SMALL CAP EQUITY FUND, L.P.   |  AQR GLOBAL RISK PREMIUM FUND III, L.P.   |  AQR OFFSHORE MULTI-STRATEGY FUND (AUD) LTD.   |  AQR DELTA OFFSHORE FUND V LTD.   |  AQR DELTA XN OFFSHORE FUND, L.P.   |  AQR OFFSHORE MULTI-STRATEGY FUND IX LTD.   |  AQR OPTIONS ENHANCED U.S. EQUITY MASTER ACCOUNT, L.P.   |  AQR REAL RETURN FUND, L.P.   |  AQR GIBRALTAR FUND II, L.P.   |  AQR GIBRALTAR OFFSHORE FUND, L.P.   |  AQR GLOBAL MACRO FUND, L.P.   |  BRIGHTLINE PARTNERS LLC   |  AQR OFFSHORE MULTI-STRATEGY FUND XII, L.P.   |  AQR OFFSHORE MULTI-STRATEGY FUND XIV, L.P.   |  AQR DELTA XN OFFSHORE FUND LTD.   |  AQR GIBRALTAR FUND, L.P.   |  AQR MULTI-STRATEGY FUND XI, L.P.   |  AQR TAX PLUS U.S. HEDGED EQUITY FUND, L.P.   |  AQR STYLE PREMIA OFFSHORE FUND II, L.P.   |  AQR GLOBAL GOVERNMENT BOND MASTER ACCOUNT, L.P.   |  AQR CORE GLOBAL GOVERNMENT BOND MASTER ACCOUNT, L.P.   |  AQR EMERGING EQUITIES FUND LP   |  AQR OFFSHORE MULTI-STRATEGY FUND XVI, L.P.   |  AGRISIGHT INC.   |  TOOLBOX OS, INC.   |  AXOSIM, INC.   |  HANOVER BANCORP, INC. /NY   |  28BIO, INC.
MIKLOS 
 
KOBOR 
DIRECTOR
MONICA 
 
METEA 
EXECUTIVE OFFICER
ALIF 
 
SALEH 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-11-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
IAN DUNN
COVINGTON ASSOCIATES LLC